SEC Form 4 · accession 0001638599-17-000109
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric K Rowinsky
Director
Period of report
Jan 1, 2017
Accepted (ET)
Jan 24, 2017 · 7:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1 | Jan 1, 2017 | A | 100,000 | $0.00 | A | 350,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase Common StockF2 | $6.25 | holding | — | — | — | — | Feb 10, 2022 | Common Stock | 15,000 | 15,000 | D |
| Options to purchase Common StockF3 | $2.10 | holding | — | — | — | — | Dec 19, 2023 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1One-third of the shares will vest on each of January 1, 2018, 2019 and 2020, and subject to continued service on the board of directors.
- F2One-third of the shares vested on each of February 10, 2013, 2014 and 2015.
- F3One-third of the shares vested on each of December 19, 2014, 2015 and 2016.